These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33483856)

  • 1. Factors associated with non-attendance in the Irish national diabetic retinopathy screening programme (INDEAR study report no. 2).
    Kelly SR; Loiselle AR; Pandey R; Combes A; Murphy C; Kavanagh H; Fitzpatrick P; Mooney T; Kearney P; Crabb DP; Keegan DJ
    Acta Diabetol; 2021 May; 58(5):643-650. PubMed ID: 33483856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of attendance at diabetic retinopathy screening among people with type 2 diabetes: Secondary analysis of data from primary care.
    O'Keeffe D; Riordan F; Harkins V; Kearney P; Mc Hugh S
    Prim Care Diabetes; 2021 Dec; 15(6):1086-1094. PubMed ID: 34518110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irish National Diabetic RetinaScreen Programme: report on five rounds of retinopathy screening and screen-positive referrals. (INDEAR study report no. 1).
    Pandey R; Morgan MM; Murphy C; Kavanagh H; Acheson R; Cahill M; McGettrick P; O'Toole L; Hamroush F; Mooney T; Byrne H; Fitzpatrick P; Keegan DJ
    Br J Ophthalmol; 2022 Mar; 106(3):409-414. PubMed ID: 33334818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Socio-economic and ethnic inequalities in diabetes retinal screening.
    Gulliford MC; Dodhia H; Chamley M; McCormick K; Mohamed M; Naithani S; Sivaprasad S
    Diabet Med; 2010 Mar; 27(3):282-8. PubMed ID: 20536490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of repeat non-attenders at Diabetes Eye Screening Wales, a national community-based diabetes-related retinopathy screening service, during 2003-2018.
    Thomas RL; Cheung WY; Rafferty JM; Luzio SD; Akbari A; Owens DR
    Diabet Med; 2021 Sep; 38(9):e14536. PubMed ID: 33545742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT.
    Broadbent DM; Wang A; Cheyne CP; James M; Lathe J; Stratton IM; Roberts J; Moitt T; Vora JP; Gabbay M; García-Fiñana M; Harding SP;
    Diabetologia; 2021 Jan; 64(1):56-69. PubMed ID: 33146763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How is the risk of being diagnosed with referable diabetic retinopathy affected by failure to attend diabetes eye screening appointments?
    Virk R; Binns AM; Chambers R; Anderson J
    Eye (Lond); 2021 Feb; 35(2):477-483. PubMed ID: 32317793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic Retinopathy Screening: A Systematic Review on Patients' Non-Attendance.
    Kashim RM; Newton P; Ojo O
    Int J Environ Res Public Health; 2018 Jan; 15(1):. PubMed ID: 29351207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cohort follow-up study for diabetic retinopathy screening incidence in the North Denmark Region.
    Nissen TPH; Vestergaard P; Vorum H; Torp-Pedersen C; Aasbjerg K
    Acta Diabetol; 2023 Nov; 60(11):1581-1590. PubMed ID: 37436529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost implications, deprivation and geodemographic segmentation analysis of non-attenders (DNA) in an established diabetic retinopathy screening programme.
    Waqar S; Bullen G; Chant S; Salman R; Vaidya B; Ling R
    Diabetes Metab Syndr; 2012; 6(4):199-202. PubMed ID: 23199538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. System-level and patient-level explanations for non-attendance at diabetic retinopathy screening in Sutton and Merton (London, UK): a qualitative analysis of a service evaluation.
    Strutton R; Du Chemin A; Stratton IM; Forster AS
    BMJ Open; 2016 May; 6(5):e010952. PubMed ID: 27194319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling the cost-effectiveness of adopting risk-stratified approaches to extended screening intervals in the national diabetic retinopathy screening programme in Scotland.
    Scotland G; McKeigue P; Philip S; Leese GP; Olson JA; Looker HC; Colhoun HM; Javanbakht M
    Diabet Med; 2016 Jul; 33(7):886-95. PubMed ID: 27040994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What works to increase attendance for diabetic retinopathy screening? An evidence synthesis and economic analysis.
    Lawrenson JG; Graham-Rowe E; Lorencatto F; Rice S; Bunce C; Francis JJ; Burr JM; Aluko P; Vale L; Peto T; Presseau J; Ivers NM; Grimshaw JM
    Health Technol Assess; 2018 May; 22(29):1-160. PubMed ID: 29855423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of geodemographic factors on the attendance rates at a regional diabetic retinopathy treatment centre.
    Greenan E; Salim M; Coakley DN; James M
    Ir J Med Sci; 2019 Nov; 188(4):1207-1212. PubMed ID: 31001789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the uptake of a national retinopathy screening programme: An audit of patients with diabetes in two large primary care centres.
    Tracey M; Racine E; Riordan F; McHugh SM; Kearney PM
    HRB Open Res; 2019; 2():17. PubMed ID: 32104778
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk of diabetic retinopathy at first screen in children at 12 and 13 years of age.
    Scanlon PH; Stratton IM; Bachmann MO; Jones C; Leese GP;
    Diabet Med; 2016 Dec; 33(12):1655-1658. PubMed ID: 27646856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reasons for poor follow-up of diabetic retinopathy patients after screening in Tanzania: a cross-sectional study.
    Mtuya C; Cleland CR; Philippin H; Paulo K; Njau B; Makupa WU; Hall C; Hall A; Courtright P; Mushi D
    BMC Ophthalmol; 2016 Jul; 16():115. PubMed ID: 27435362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of Autonomous Point-of-Care Diabetic Retinopathy Screening for Pediatric Patients With Diabetes.
    Wolf RM; Channa R; Abramoff MD; Lehmann HP
    JAMA Ophthalmol; 2020 Oct; 138(10):1063-1069. PubMed ID: 32880616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service.
    Thomas RL; Dunstan FD; Luzio SD; Chowdhury SR; North RV; Hale SL; Gibbins RL; Owens DR
    Br J Ophthalmol; 2015 Jan; 99(1):64-8. PubMed ID: 25091950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equity of uptake of a diabetic retinopathy screening programme in a geographically and socio-economically diverse population.
    Orton E; Forbes-Haley A; Tunbridge L; Cohen S
    Public Health; 2013 Sep; 127(9):814-21. PubMed ID: 23973045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.